First report of a salmonella enterica serovar typhimurium isolate with carbapenemase (KPC-2) in Colombia

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1263-1264

  Rodriguez E ^a   Bautista, A ^a   Barrero, L ^b  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b HAI   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CARBAPENEMASE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; NALIDIXIC ACID; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; COLOMBIA; DISK DIFFUSION; ENZYME INDUCTION; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE;

BETA-LACTAMASES; COLOMBIA; ELECTROPHORESIS, GEL, PULSED-FIELD; FECES; FEMALE; GENE EXPRESSION; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 84893475318     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02423-13     Document Type: Letter

References (8)

1. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM. 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47:1297-1300. http://dx.doi.org/10.1128/AAC.47.4.1297-1300.2003.
2. Fischer J, Schmoger S, Jahn S, Helmuth R, Guerra B. 30 June 2013. NDM-1 carbapenemase-producing Salmonella enterica subsp. enterica serovar Corvallis isolated from a wild bird in Germany. J. Antimicrob. Chemother. http://dx.doi.org/10.1093/jac/dkt260.
3. Woodford N, Wareham DW, Guerra B, Teale C. 3 October 2013. Carbapenemase-producing enterobacteriaceae and non-enterobacteriaceae from animals and the environment: an emerging public health risk of our own making? J. Antimicrob. Chemother. http://dx.doi.org/10.1093/jac/dkt392.
4. Instituto Nacional de Salud. 2013. Evolución de la sensibilidad antimicrobiana de bacterias implicadas en eventos de interés en salud pública. Instituto Nacional de Salud, Bogotá, Colombia. http://www.ins.gov.co/tramites-y-servi cios/examenes-de-inter%C3%A9s-en-salud- publica/Microbiologa/Datos%2 0resistencia%202012%20CIA%20EC0%2007%2005%2013.pdf.
5. Patrick AD, François-Xavier W. 2007. Antigenic formulas of the Salmonella serovars, 9th revision. WHO Collaborating Centre for Reference Research on Salmonella, Institute Pasteur, Paris, France.
6. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67. http://dx.doi.org/10.1089/fpd.2006.3. 59.
8. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. 2013. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect. Dis. 13:785-796. http://dx.doi.org/10. 1016/S1473-3099(13)70190-7.